| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 96 |
| 1 | INFLIXIMAB | 70 |
| 2 | PREDNISONE | 70 |
| 3 | ACETAMINOPHEN | 41 |
| 4 | DIPHENHYDRAMINE HYDROCHLORIDE | 36 |
| 5 | LEVOTHYROXINE SODIUM | 33 |
| 6 | RITUXIMAB | 32 |
| 7 | METHOTREXATE SODIUM | 31 |
| 8 | ERGOCALCIFEROL | 30 |
| 9 | NATALIZUMAB | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | 1 | 0.0769 |
| 1 | HUMAN RABIES VIRUS IMMUNE GLOBULIN | 1 | 0.0156 |
| 2 | VILTOLARSEN | 2 | 0.0118 |
| 3 | ALLOPURINOL SODIUM | 6 | 0.0106 |
| 4 | BENZYL ALCOHOL | 1 | 0.0095 |
| 5 | HYPOCHLOROUS ACID | 1 | 0.0093 |
| 6 | AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE | 1 | 0.0085 |
| 7 | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | 1 | 0.0068 |
| 8 | INFLIXIMAB-DYYB | 22 | 0.0064 |
| 9 | COCOA BUTTER, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0054 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 129 |
| 1 | Corticosteroid [EPC] | 118 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 65 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 59 |
| 4 | Integrin Receptor Antagonist [EPC] | 44 |
| 5 | Proton Pump Inhibitor [EPC] | 37 |
| 6 | Benzodiazepine [EPC] | 36 |
| 7 | Vitamin C [EPC] | 35 |
| 8 | Aminosalicylate [EPC] | 34 |
| 9 | Provitamin D2 Compound [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 1 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 6 | 0.0018 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Neonatal Fc Receptor Blocker [EPC] | 5 | 0.0011 |
| 4 | Provitamin D2 Compound [EPC] | 30 | 0.0010 |
| 5 | Human Immunoglobulin G [EPC] | 20 | 0.0009 |
| 6 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 8 | Nitrogen Binding Agent [EPC] | 2 | 0.0008 |
| 9 | Leptin Analog [EPC] | 1 | 0.0008 |